Alpha Cognition Inc

ACOG | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.97

$0 (0.00%)

Sep 22, 2026, 11:06 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Aug 24, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $139.32M

1D Range

8.85 9.07

52W Range

4.50 10.14

Valuation (TTM)

PE -8.08

PB 2.63

EV/EBITDA -3.55

Valuation (NTM)

Forward PE 0.23

Forward PEG 0.15

Price Target $17.25

Cash Flow

FCF Yield -22.4%

SBC Adj. FCF Yield -25.1%

SBC Impact -12.2%

Margins

Gross Margin 89.9%

Operating Margin -190.6%

FCF Margin -204.6%

Growth (CAGR)

Revenue 3Y | 5Y 115.3% | 88.5%

Dil EPS 3Y | 5Y 57.6% | 42.5%

FCF 3Y | 5Y -70.0% | -20.2%

Returns

ROA -36.3%

ROE -45.3%

ROIC -50.0%

Financial Health

Net Cash

$41.38M

Current Ratio 9.03

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commer...

Sector Healthcare

Industry Biotechnology

Employees 71

IPO Date Nov 11, 2024

Website www.alphacognition.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 12, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$18.50

Upside

+106.24%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞